RAMP3 deficiency enhances postmenopausal obesity and metabolic disorders
Sign Up to like & getrecommendations! Published in 2018 at "Peptides"
DOI: 10.1016/j.peptides.2018.10.006
Abstract: &NA; There is a marked increase in the incidence of visceral adiposity and insulin resistance among women following menopause. Adrenomedullin (AM) is an endogenous peptide first identified as a vasodilator, but now known to exert… read more here.
Keywords: ramp3 ovx; ovx mice; ramp3; postmenopausal obesity ... See more keywords